Kyntra Bio KYNB Ratios (2014-2026)

NASDAQ KYNB
$7.89 -0.15 (-1.86%)
As of: Sep 10, 2026 · 1:41 PM EDT
Reported Financials

Kyntra Bio Quarterly Ratios

Periods 50 quarters
Latest Jun 2026

Kyntra Bio reported a gross margin of 99.86% and a net margin of 812.35% for the quarter ended Jun 2026. These financial ratios cover 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
97.91%81.11%93.03%77.16%72.62%41.37%90.35%87.12%89.43%87.16%15.85%85.97%39.02%286.48%90.80%93.69%94.61%78.23%-9.84%99.86%
EBT Margin
31.78%-811.88%-104.25%-245.47%-584.32%-789.85%-214.12%-199.61%-159.98%126.16%-193.34%-4,747.09%-39,259.35%-276.33%-612.05%-1,021.88%-1,221.75%-1,144.09%-404.82%812.28%
EBIT Margin
32.68%-817.51%-103.56%-262.44%-595.21%-787.52%-210.42%-198.67%-158.18%128.84%-193.90%-4,650.10%-38,773.98%-227.53%-544.72%-894.07%-502.88%-1,058.10%-369.66%-1,192.27%
EBITDA Margin
32.68%-817.51%-103.56%-262.44%-595.21%-787.52%-210.42%-198.67%-158.18%128.84%-193.90%-4,650.10%-38,773.98%-227.53%-544.72%-894.07%-502.88%-1,058.10%-369.66%-1,192.27%
Operating Margin
32.68%-817.51%-103.56%-262.44%-595.21%-787.52%-210.42%-198.67%-158.18%128.84%-193.90%-4,650.10%-38,773.98%-227.53%-544.72%-894.07%-502.88%-1,058.10%-369.66%-1,192.27%
Net Margin
31.71%-812.56%-104.44%-245.55%-585.05%-791.13%-214.32%-199.08%-160.19%125.93%-129.84%-1,557.52%-13,889.43%573.59%169.37%-564.02%18,646.47%-161.94%-406.58%812.35%
FCF Margin
27.36%-340.66%-16.63%-113.97%-335.21%-629.12%-282.58%-251.73%-212.34%25.16%-233.86%-3,996.29%-6,876.42%-976.30%98.69%939.84%-172.49%-1,435.24%-371.51%-270.76%
Efficiency
Inventory AverageInventory Avg.
26.92M30.16M37.04M41.98M40.42M40.19M41.45M41.82M40.94M28.93M22.25M26.37M24.67M13.55M3.15M3.51M3.86M3.80M3.56M3.38M
Assets AverageAssets Avg.
829.57M812.17M759.88M716.36M647.81M609.46M574.32M526.84M487.78M441.98M394.70M329.54M278.81M239.47M189.87M171.63M157.53M128.30M114.61M105.35M
Invested CapitalInvested Cap.
-21.45M-10.38M-85.50M-132.23M-135.42M-139.38M-170.89M-152.51M-122.99M-128.78M-17.03M-30.04M-10.94M
Asset Utilization RatioAsset Util.
0.340.290.340.370.190.190.160.200.260.110.09-0.02-0.170.120.040.040.050.050.060.07
Leverage & Solvency
Interest Coverage RatioInterest Cover
467.65-0.00M-649.41-554.78-0.00M-59.12-32.08-28.69-12.6440.14-16.96-24.84-23.05-3.22-6.61-6.00-2.60-5.60-5.69-7.42
Debt Ratio
0.140.160.170.200.250.280.340.440.410.19
Times Interest Earned
467.65-0.00M-649.41-554.78-0.00M-59.12-32.08-28.69-12.6440.14-16.96-24.84-23.05-3.22-6.61-6.00-2.60-5.60-5.69-7.42
Valuation
Price to EarningsP/E
19.16-9.74-17.65-13.52-13.28-22.70-23.26-3.01-1.32-0.94-7.10-5.76-2.362.976.75-2.820.25-17.18-1.812.55
Price to SalesP/S
6.0779.1618.4333.2177.67179.5949.865.982.11-1.199.2289.77327.2217.0511.4315.9046.0527.837.3420.74
Price to BookP/B
2.755.726.308.0026.41-70.34-62.42-3.24-0.54-0.43-1.13-0.42-0.17-0.24-0.16-0.11-2.91-1.18-0.89-1.01
Enterprise Value
480.34M924.40M713.23M571.65M833.55M1,086.53M1,467.00M-49.09M-145.00M-126.56M77.64M-51.54M-69.28M-33.23M12.70M15.06M-69.38M-31.97M-38.31M-39.27M
EV to EBIT
9.42-6.84-11.32-7.31-8.90-16.42-19.280.562.281.33-1.581.111.454.66-0.85-1.2512.822.372.772.23
EV to EBITDA
9.42-6.84-11.32-7.31-8.90-16.42-19.280.562.281.33-1.581.111.454.66-0.85-1.2512.822.372.772.23
Market Capitalization
947.48M1,309.62M1,121.33M989.82M1,222.11M1,508.54M1,802.99M265.15M84.86M87.54M233.76M89.59M40.25M53.44M31.32M21.43M49.55M35.53M27.45M30.57M
Price to FCFP/FCF
22.20-23.24-110.87-29.14-23.17-28.55-17.64-2.38-1.00-4.71-3.94-2.25-4.76-1.7511.591.69-26.70-1.94-1.98-7.66
EV to FCF
11.25-16.40-70.52-16.83-15.80-20.56-14.360.441.706.81-1.311.298.191.094.701.1937.381.742.769.84
EV to CFO
10.85-16.82-84.15-17.29-16.07-20.69-14.440.441.726.91-1.311.298.271.094.671.1937.561.742.769.84
Return Ratios
Return on Sales [ROS]ROS
32.68%-817.51%-103.56%-262.44%-595.21%-787.52%-210.42%-198.67%-158.18%128.84%-193.90%-4,650.10%-38,773.98%-227.53%-544.72%-894.07%-502.88%-1,058.10%-369.66%-1,192.27%
Return on Capital Employed [ROCE]ROCE
-34.06%-49.18%-55.72%-47.37%-93.51%-89.62%-98.30%-97.35%-105.54%-143.87%-149.43%-140.47%-270.02%-141.68%-99.72%-519.71%-32.51%-46.33%-51.79%-72.59%
Return on Invested Capital [ROIC]ROIC
612.84%296.20%220.80%184.72%153.38%92.86%84.13%64.92%54.11%154.07%
Return on Assets [ROA]ROA
-25.92%-35.83%-37.25%-30.95%-56.06%-48.44%-53.84%-61.55%-60.78%-73.07%-70.54%-62.43%-56.85%-19.87%-5.27%-1.20%136.89%152.45%153.36%185.42%